Completed OBSERVATIONAL NCT00880711

Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC) (FIONA)

Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer

Sponsor: AstraZeneca

Updated 7 times since 2017 Last updated: Nov 29, 2011 Started: Apr 30, 2009 Primary completion: Sep 30, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Breast Cancer, this trial is completed. The trial is conducted by AstraZeneca and has accumulated 7 data snapshots since 2009. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca

Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Graz, Austria , Innsbruck, Austria , Klagenfurt, Austria , Leoben, Austria , Linz, Austria , Oberpullendorf, Austria , Rankweil, Austria , Rottenmann, Austria , Salzburg, Austria , Sankt Veit im Pongau, Austria and 3 more locations